Acadian Asset Management LLC Assertio Holdings, Inc. Transaction History

Acadian Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	SELL	$5.0 - $7.66 $4.91 Million - $7.52 Million	-982,033 Reduced 85.06%	172,496 $934,000
Q1 2023 May 11, 2023	BUY	$3.54 - $6.66 $29,438 - $55,384	8,316 Added 0.73%	1,154,529 $7.35 Million
Q4 2022 Feb 14, 2023	SELL	$2.11 - $4.3 $907,740 - $1.85 Million	-430,209 Reduced 27.29%	1,146,213 $4.93 Million
Q3 2022 Nov 14, 2022	BUY	$2.13 - $4.0 $1.48 Million - $2.79 Million	696,495 Added 79.15%	1,576,422 $3.58 Million
Q2 2022 Aug 09, 2022	BUY	$1.88 - $3.42 $1.3 Million - $2.36 Million	690,844 Added 365.37%	879,927 $2.6 Million
Q1 2022 May 12, 2022	BUY	$2.06 - $3.0 $389,510 - $567,249	189,083 New	189,083 $540,000

31M

957K

38.5K

Ticker ASRT
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 48,178,200
Market Cap $41.9M
Description
Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.